Premenstrual syndrome. Evidence-based treatment in family practice

Canadian Family Physician

Volumn 48, Issue NOV., 2002, Pages 1789-1797

  Douglas, Sue ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BROMOCRIPTINE; CALCIUM CARBONATE; DANAZOL; ESTRADIOL; FLUOXETINE; FLUVOXAMINE; GESTAGEN; GONADORELIN; MAGNESIUM; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PLACEBO; PRIMROSE OIL; PROGESTERONE; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE;

ARTICLE; BREAKTHROUGH BLEEDING; CARBOHYDRATE DIET; CLINICAL STUDY; COCHRANE LIBRARY; COGNITIVE THERAPY; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DYSMENORRHEA; EVIDENCE BASED MEDICINE; EXERCISE; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; GENERAL PRACTICE; HEADACHE; HUMAN; INSOMNIA; LIFESTYLE; MEDLINE; MOOD DISORDER; NERVOUSNESS; PATIENT CARE; PRACTICE GUIDELINE; PREMENSTRUAL SYNDROME; SENSORY DYSFUNCTION; SEXUAL DYSFUNCTION; STRESS; TREATMENT FAILURE;

ADULT; AFFECT; CALCIUM CARBONATE; CONTRACEPTIVES, ORAL; DIET; EVIDENCE-BASED MEDICINE; EXERCISE; FAMILY PRACTICE; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; PRACTICE GUIDELINES; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 0036855663     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. O'Brien PM. Helping women with premenstrual syndrome. BMJ 1993;307:1471-5.
2. Chakmajian ZH. A critical assessment of therapy for premenstrual tension syndrome. J Reprod Med 1983;28:532-8.
3. 6 in premenstrual syndrome (Protocol for a Cochrane review). In: The Cochrane Library. Oxford, Engl: Update Software; 1999. Issue 4.
4. Wyatt KM, Dimmock PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999;318:1375-81.
5. Strid J, Jepson R, Moore V, Kleijen J, Iasco SM. Evening primrose oil or other essential fatty acids for pre-menstrual syndrome (Protocol for a Cochrane review). In: The Cochrane Library. Oxford, Engl; Update Software; 1999. Issue 4.
6. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998;179(2):444-52.
7. Wyatt KM, Drimmock PW, O'Brien PMS. Selective serotonin reuptake inhibitors for premenstrual syndrome (Protocol for a Cochrane review). In: The Cochrane Library. Oxford, Engl: Update Software; 1999. Issue 4.
8. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356(Sept 30):1131-6.
9. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 1999;14(Suppl 2):S27-33.
10. Johnson SR. Pre-menstrual syndrome therapy. Clin Obstet Gynecol 1998;41(2):405-21.
11. Sayegh R, Schiff I, Wurtman J, Spiers P, McDermott J, Wurtman R. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual symptoms. Obstet Gynecol 1995;86:520-8.
12. Aganoff JA, Boyle GJ. Aerobic exercise, mood states, and menstrual cycle symptoms. J Psychosom Res 1994;38:183-92.
13. Steege JF, Blumenthal JA. The effect of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res 1993;37:127-33.
14. Prior JC, Vigna Y, Sciarretta D, Alojado N, Schulzer M. Conditioning exercise decreases premenstrual symptoms: a prospective controlled 6-month trial. Fertil Steril 1987;47:402-8.
15. Woods NF, Most A, Longenecker GD. Major life events, daily stressors, and perimenstrual symptoms. Nurs Res 1985;33:263-7.
16. Kirby RJ. Changes in premenstrual symptoms and irrational thinking following cognitive behavioural coping skills training. J Consult Clin Psychol 1994;62:1026-32.
17. Goodale IL, Domar AD, Benson H. Alleviation of premenstrual symptoms with the relaxation response. Obstet Gynecol 1990;75:649-55.
18. Christensen AP, Oei TP. The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric change. J Affect Disord 1995;33:57-63.
19. 6. In: Vitamins. New York, NY: De Gruyter, 1988. p. 543-618.
20. Jellin JM, Batz F, Hitchens K. Pharmacists letter/Prescriber's letter; Natural Comprehensive Database. Stockton, Calif: Therapeutic Research Faculty; 1999. p. 330-1, 550-1.
21. Budeiri D, Li Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996;17:60-8.
22. Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992;36:257-66.
23. Graham CA, Sherwin BB. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use. J Psychosom Res 1987;31:45-53.
24. Bancroft J, Rennie D. The impact of oral contraceptive use on perimenstrual mood, clumsiness, food cravings, and other symptoms. J Psychosom Res 1993;37:195-202.
25. West CP. Inhibition of ovulation with oral progestins - effectiveness in premenstrual syndrome. Eur J Obstet Gynecol Reprod Biol 1990;34:119-28.
26. Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RG, Genazzani AR. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991;78:177-81.
27. Walker AF, De Souza MC, Vickers MF, Abeyasekera S, Collins ML, Trinca LA. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998;7(9):1157-65.
28. London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of premenstrual syndrome. J Reprod Med 1987;32(6):400-4.
29. O'Brien PM, Craven D, Selby C, Symonds EM. Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol 1979;86:142-7.
30. Vellacott ID, Shroff NE, Pearce MY, Stratford ME, Akbar FA. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. Curr Med Res Opin 1987;10:450-6.
31. Wood C, Jacubowicz D. The treatment of premenstrual symptoms with mefenamic acid. Br J Obstet Gynecol 1980;87:627-30.
32. Mira M, McNeil D, Fraser IS, Vizzard J, Abraham S. Mefenamic acid in the treatment of premenstrual syndrome. Obstet Gynecol 1986;68:395-8.
33. Facchinetti F, Fioroni L, Sances G, Romano G, Nappi G, Genazzani AR. Naproxen sodium in the treatment of premenstrual symptoms. A placebo controlled study. Gynecol Obstet Invest 1989;28:205-8.
34. Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;2:730-2.
35. Smith RN, Studd JW, Zamblera D, Holland EF. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of topical oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynecol 1995;102:475-84.
36. Dalton K. The premenstrual syndrome and progesterone therapy. 2nd ed. Chicago, Ill: Year Book Medical Publisher, 1984.
37. Freeman E, Rickels K, Soundheimer SJ, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 1990;264:349-53.
38. Andersch B, Hahn L. Progesterone treatment of premenstral tension - a double blind study. J Psychosom Res 1985;29:489-93.
39. Maddock S, Hahn P, Moller F, Reid RL. A double blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am J Obstet Gynecol 1986;154:573-81.
40. Sampson GA. Premenstrual syndrome: a double-blind trial of progesterone and placebo. Br J Psychiatry 1979;135:209-15.
41. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001;323:776-80.
42. Andersch B. Bromocriptine and premenstrual syndrome: a survey of double-blind trials. Obstet Gynecol Surv 1983;38:643-6.
43. Meden-Vrtovec H, Vujic D. Bromocriptine in the management of premenstrual syndrome. Clin Esp Obstet Gynecol 1992;19(4):242-8.